Research output per year
Research output per year
Personal profile
In Korean
권태균 교수(의과대학 의학과)
Education
(1999) Ph. D., Kyungpook National University
(1988) MD., School of Medicine, Kyungpook National University
(1988) MD., School of Medicine, Kyungpook National University
Professional Experience
1996-1998 Instructor, Dept of Urology, Kyungpook National University
1998-2003 Assistant Professor, Dept of Urology, Kyungpook National University
2003-2008 Associate Professor, Dept of Urology, Kyungpook National University
2008- Professor, Dept of Urology, Kyungpook National University
1998-2003 Assistant Professor, Dept of Urology, Kyungpook National University
2003-2008 Associate Professor, Dept of Urology, Kyungpook National University
2008- Professor, Dept of Urology, Kyungpook National University
Research Interests
Tissue engineering and regenerative medicine
Cell therapy
Urological oncology – clinical research and translational research
Cell therapy
Urological oncology – clinical research and translational research
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Tae Gyun Kwon is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Comparison of Short-Term Outcomes and Safety Profiles between Androgen Deprivation Therapy+Abiraterone/Prednisone and Androgen Deprivation Therapy+Docetaxel in Patients with De Novo Metastatic Hormone-Sensitive Prostate Cancer
Korean Urologic Oncology Society Prostate Cancer Group, Jul 2024, In: World Journal of Men's Health. 42, 3, p. 620-629 10 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study
The CLEAR Trial Investigators, 10 Apr 2024, In: Journal of Clinical Oncology. 42, 11, p. 1222-1228 7 p.Research output: Contribution to journal › Article › peer-review
Open Access29 Scopus citations -
Multiplexed PLGA scaffolds with nitric oxide-releasing zinc oxide and melatonin-modulated extracellular vesicles for severe chronic kidney disease
Rhim, W. K., Woo, J., Kim, J. Y., Lee, E. H., Cha, S. G., Kim, D. S., Baek, S. W., Park, C. G., Kim, B. S., Kwon, T. G. & Han, D. K., 2024, (Accepted/In press) In: Journal of Advanced Research.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Pathologic fractures of the humerus during adjuvant pembrolizumab in patients with renal cell carcinoma after radical nephrectomy: A case report
Kang, J. K., Lee, E. H., Lee, J. N., Kim, T. H., Kwon, T. G. & Chung, J. W., Feb 2024, In: International Journal of Surgery Case Reports. 115, 109290.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Pathologic fractures of the humerus during adjuvant pembrolizumab in patients with renal cell carcinoma after radical nephrectomy: A case report
Tae Gyun, K., 2024, In: Int J Surg Case Rep ..Research output: Contribution to journal › Article › peer-review